Overview
Glycemic Variability of Combination Therapies in T2DM
Description
A multicenter study to evaluate efficacy and safety
Eligibility
Inclusion Criteria:
- Inadequate glycemic control despite treatment with Metformin (≥ 1,000mg/day) and SGLT-2 inhibitor.
Exclusion Criteria:
- History of acute or chronic metabolic acidosis
- Moderate to severe renal impairment (eGFR \< 45 mL/min/1.73m²)
- Severe hepatic impairment
- History of heart failure (NYHA Class III/IV)
